Physician Assistant Exam Review

  • About
  • Contact
  • Blueprint
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
You are here: Home / Neurology / 127: Cranial Nerve Palsies – Part 1

127: Cranial Nerve Palsies – Part 1

https://traffic.libsyn.com/physicianassistantexamreview/127_CN_Palsies_part_1.mp3

Podcast: Play in new window | Download

Cranial Nerves Overview

1. Olfactory – CN I – Smell

  • Detects odors and sends smell information to the brain.

2. Optic – CN II – Vision

  • Transmits visual information from the eyes to the brain.

3. Oculomotor – CN III – Eye movement, pupil constriction, eyelid control

  • Moves the eye in most directions:
    • Up – superior rectus
    • Down – inferior rectus
    • Inward toward the nose – medial rectus
    • Up and out diagonally – inferior oblique
  • Controls pupil constriction, making the pupil smaller in bright light.
  • Lifts the eyelid, preventing drooping or ptosis.

4. Trochlear – CN IV – Eye movement down and inward

  • Moves the eye down and inward toward the nose.
  • Helps with looking at objects close to you, like reading a book.

5. Trigeminal – CN V – Facial sensation and chewing

  • Feels touch, pain, and temperature from the face.
  • Moves the muscles used for biting and chewing.

6. Abducens – CN VI – Eye movement side to side

  • Moves the eye outward, away from the nose.

7. Facial – CN VII – Facial movement, taste, tear and saliva production

  • Controls facial expressions like smiling, frowning, and closing eyes.
  • Provides taste sensation from the front two-thirds of the tongue.
  • Controls tear glands, keeping eyes moist.
  • Controls salivary glands, keeping the mouth moist.

8. Vestibulocochlear – CN VIII – Hearing and balance

  • Detects sound from the inner ear.
  • Helps maintain balance and spatial orientation.

9. Glossopharyngeal – CN IX – Taste, swallowing, saliva, blood pressure reflex

  • Provides taste sensation from the back one-third of the tongue.
  • Helps move food down the throat during swallowing.
  • Controls the parotid salivary gland.
  • Senses blood pressure changes in the carotid artery.

10. Vagus – CN X – Autonomic control, swallowing, voice, gag reflex

  • Controls automatic body functions like heart rate, breathing, and digestion.
  • Assists with swallowing.
  • Controls vocal cord movement, affecting the voice.
  • Plays a role in the gag reflex to protect from choking.

11. Accessory – CN XI – Shoulder shrug and head turn

  • Turns the head using the sternocleidomastoid muscle.
  • Shrugs the shoulders using the trapezius muscle.

12. Hypoglossal – CN XII – Tongue movement

  • Moves the tongue for speaking, eating, and swallowing.

Cranial Nerve Palsies – Overview & Definition

Definition

  • Cranial nerve palsy – dysfunction or paralysis of one or more cranial nerves, leading to motor, sensory, or autonomic deficits.
  • May be isolated or involve multiple nerves.
  • Causes include vascular, traumatic, inflammatory, compressive, infectious, metabolic, or degenerative diseases.

Classification

Cranial nerve palsies are categorized based on their function and presentation:

  1. Motor nerve palsies – affect eye movements, swallowing, or facial expressions (CN III, IV, VI, VII, IX, X, XI, XII).
  2. Sensory nerve palsies – affect vision, hearing, or sensation (CN I, II, V, VIII).
  3. Mixed motor-sensory palsies – affect both movement and sensation (CN V, IX, X).

General Clinical Features

  • Motor deficits – weakness, paralysis, atrophy of muscles
  • Sensory deficits – numbness, pain, loss of smell, vision, or hearing
  • Autonomic dysfunction – abnormal pupillary responses, dry eyes, excessive salivation or lacrimation

Common Causes of Cranial Nerve Palsies

  • Vascular – stroke, giant cell arteritis
  • Trauma – skull fractures, cribriform plate damage (CN I), direct nerve injury
  • Tumors – acoustic neuroma (CN VIII), meningiomas, skull base tumors
  • Infectious – meningitis, Lyme disease, herpes zoster, Ramsay Hunt syndrome
  • Demyelinating – multiple sclerosis (CN II, V, VII involvement common)
  • Neuromuscular disorders – myasthenia gravis (affecting CN III, IV, VI)
  • Idiopathic – Bell’s palsy (CN VII), Tolosa-Hunt syndrome (CN III, IV, VI)

Diagnosis

  • Clinical history and exam – pattern of weakness, sensory deficits, associated symptoms
  • Neuroimaging – MRI/CT – rule out stroke, tumors, demyelination
  • Electrophysiology – EMG, nerve conduction studies – if suspected neuropathy
  • Blood tests – ESR, CRP, Lyme serology, glucose, B12, autoimmune panels

General Treatment Principles

Supportive care – physical therapy, eye protection, symptomatic treatment

Address underlying cause – vascular, infectious, inflammatory, neoplastic

Steroids – if inflammatory, Bell’s palsy or optic neuritis

Antibiotics/antivirals – if infectious, Lyme disease or herpes zoster

Surgical decompression – if compressive lesion or tumor


CN I – Olfactory Nerve Palsy

  • Dysfunction of the olfactory nerve (CN I), responsible for smell perception.

Clinical Presentation

  • Loss of smell – anosmia, unilateral or bilateral
  • Altered taste perception – often due to smell impairment
  • Parosmia – distorted smells, e.g., burnt or rotten odors
  • Cacosmia – perceiving foul odors that aren’t present

Physical Exam

  • Olfactory testing – identify non-irritating scents like coffee or vanilla
  • Nasal exam – assess for obstructions, polyps, or sinus disease

Labs, Studies, and Imaging

  • MRI brain – rule out tumor, neurodegenerative disease, or trauma
  • CT sinuses – if chronic sinus disease or nasal polyps suspected
  • COVID-19 testing – if acute anosmia without nasal congestion

Common Causes

  • Head trauma
  • Neurodegenerative diseases – Parkinson’s, Alzheimer’s
  • Viral infections – including COVID-19

Treatment

  • Address underlying cause – sinus disease, neurodegeneration
  • Olfactory training therapy – daily exposure to different scents
  • Supportive care for post-viral anosmia – smell often returns over time

Key Takeaways

  • Anosmia can be an early sign of neurodegenerative disease (Parkinson’s, Alzheimer’s).
  • Head trauma can permanently damage CN I.
  • Post-viral anosmia (e.g., COVID-19) may last weeks to months.

CN II – Optic Nerve Palsy

  • Dysfunction of the optic nerve (CN II), which transmits visual signals from the retina to the brain.

Clinical Presentation

  • Unilateral or bilateral vision loss
  • Decreased visual acuity – blurry or dim vision
  • Loss of color vision – red desaturation, early sign of optic neuritis
  • Relative afferent pupillary defect (RAPD) – abnormal light reflex, pupil doesn’t constrict normally

Physical Exam

  • Visual acuity testing – Snellen chart
  • Fundoscopic exam
    • Optic disc swelling (papilledema) – increased ICP
    • Pale optic disc (optic atrophy) – chronic optic neuropathy
    • Blurred disc margins (optic neuritis) – inflammatory cause, often MS
  • Swinging flashlight test
    • Normal – light in either eye causes both pupils to constrict equally
    • RAPD (CN II defect) – light in the affected eye causes both pupils to dilate instead of constricting

Labs, Studies, and Imaging

  • MRI brain with contrast – rule out optic neuritis (MS), tumor, or stroke
  • Lumbar puncture with oligoclonal bands – if MS-related optic neuritis suspected
  • ESR, CRP, temporal artery biopsy – if giant cell arteritis suspected
  • Fluorescein angiography – if vascular optic neuropathy suspected

Common Causes

  • Optic neuritis – MS, autoimmune diseases – young female, painful vision loss
  • Ischemic optic neuropathy – GCA, diabetes, hypertension – sudden, painless vision loss
  • Papilledema – increased ICP (tumor, pseudotumor cerebri) – bilateral optic disc swelling
  • Glaucoma – optic nerve damage from high intraocular pressure
  • Toxic optic neuropathy – methanol poisoning, ethambutol, amiodarone
  • Trauma – direct optic nerve injury

Treatment

  • Optic neuritis (MS-related) → IV steroids (methylprednisolone)
  • Giant cell arteritis → High-dose steroids immediately (to prevent blindness)
  • Papilledema → Treat increased ICP – acetazolamide (↓ CSF production), VP shunt, weight loss in obese patients
  • Glaucoma → Pressure-lowering medications – latanoprost, timolol, acetazolamide
  • Toxic optic neuropathy → Remove offending agent, supportive care

Key Takeaways

  • Painful vision loss? Think optic neuritis (MS until proven otherwise).
  • Painless, sudden vision loss? Think ischemic optic neuropathy (GCA, stroke, diabetes).
  • Bilateral optic disc swelling = papilledema (increased ICP, rule out brain mass).

CN III – Oculomotor Nerve Palsy

  • Dysfunction of the oculomotor nerve (CN III), leading to eye movement impairment, ptosis, and pupillary dysfunction.
  • Pupil-involving – emergent, usually compressive
  • Pupil-sparing – less concerning, often ischemic

Clinical Presentation

  • “Down and out” eye – lateral and downward deviation (unopposed CN IV & VI)
  • Ptosis – weakness of levator palpebrae superioris
  • Diplopia – double vision
  • Mydriasis (blown pupil) if pupil-involving – suggests aneurysm or mass
  • Loss of accommodation – blurry near vision

Physical Exam

  • EOM testing – limited upward, downward, and medial movement
  • Ptosis
  • Pupil involvement:
    • Dilated & non-reactive → EMERGENT – aneurysm, herniation, mass
    • Normal pupil → Likely ischemic – diabetes, hypertension

Labs, Studies, and Imaging

  • CT or MRI with contrast – rule out aneurysm, especially posterior communicating artery aneurysm
  • MRA or CTA – if vascular cause suspected
  • Blood glucose, A1C – if pupil-sparing, consider diabetic microvascular disease
  • ESR, CRP – if giant cell arteritis suspected, especially in elderly

Treatment

  • Compressive (pupil-involving causes like aneurysm, tumor, herniation) → NEUROSURGICAL EMERGENCY
  • Ischemic (pupil-sparing, often diabetic) → Observation, glycemic & BP control
  • Strabismus correction – prism glasses if persistent diplopia
  • Steroids – if inflammatory cause (giant cell arteritis, Tolosa-Hunt syndrome)

Key Takeaways

  • Pupil-involving CN III palsy = life-threatening until proven otherwise.
  • Most common ischemic cause = diabetes.
  • Most common compressive cause = posterior communicating artery aneurysm.

CN V – Trigeminal Nerve Palsy

  • Dysfunction of the trigeminal nerve (CN V), which provides sensory innervation to the face and motor control of mastication muscles.
  • Can affect one or more of its three divisions:
    • V1 – Ophthalmic → Forehead, cornea, upper eyelid sensation
    • V2 – Maxillary → Cheek, upper lip, nasal mucosa sensation
    • V3 – Mandibular → Jaw movement, lower lip sensation

Clinical Presentation

  • Facial numbness or paresthesia – depends on affected division
  • Jaw deviation toward the affected side – loss of V3 motor function
  • Trigeminal neuralgia – nerve irritation rather than true palsy
    • Severe, episodic, electric-shock-like facial pain
    • Triggered by light touch, chewing, cold air
    • Most commonly affects V2 or V3
  • Corneal reflex absent – if V1 lesion
  • Difficulty chewing – if V3 affected

Physical Exam

  • Sensory testing – loss of sensation in V1, V2, or V3 distribution
  • Jaw testing – weakness in mastication, jaw deviates toward lesion
  • Corneal reflex – absent blink reflex on affected side (V1 involvement)
  • Trigger zones – if trigeminal neuralgia, light touch may trigger severe pain

Labs, Studies, and Imaging

  • MRI brain with contrast – rule out mass (e.g., cerebellopontine angle tumor) or multiple sclerosis
  • CT head – if trauma or skull fracture suspected
  • ESR, CRP – if giant cell arteritis suspected, especially in elderly
  • Lumbar puncture – if concern for infection like herpes zoster or meningitis

Common Causes

  • Trigeminal neuralgia – most common idiopathic cause
  • Multiple sclerosis – consider in young adults with bilateral symptoms
  • Cerebellopontine angle tumors – acoustic neuroma, meningioma
  • Herpes zoster – Ramsay Hunt syndrome if CN VII also involved
  • Brainstem stroke – lateral medullary syndrome (Wallenberg)
  • Trauma – fractures affecting trigeminal branches

Treatment

  • Trigeminal neuralgia → Carbamazepine (1st line), oxcarbazepine
  • MS-related → Disease-modifying therapy – interferon-beta, natalizumab
  • Post-herpetic neuralgia → Gabapentin, pregabalin, TCAs
  • Tumor-related → Neurosurgical evaluation
  • Pain refractory to meds → Surgical decompression – microvascular decompression, radiofrequency ablation

Key Takeaways

  • Trigeminal neuralgia = shock-like, unilateral facial pain (V2, V3).
  • MS should be suspected in young patients with bilateral symptoms.
  • Absent corneal reflex suggests V1 involvement.
  • Jaw deviation occurs toward the side of the lesion.

  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails

logo Privacy Policy | Fulfillment Policy | Terms of Service | Web design by OptimWise